- 現金殖利率: 4.21%、總殖利率: 4.21%、5年平均現金配發率: 81.14%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 0.67 | -76.82 | 1.00 | -66.67 | 0.00 | 0 | 149.25 | 43.78 | 0.00 | 0 | 149.25 | 43.78 |
| 2022 (9) | 2.89 | -42.66 | 3.00 | -25.0 | 0.00 | 0 | 103.81 | 30.8 | 0.00 | 0 | 103.81 | 30.8 |
| 2021 (8) | 5.04 | 76.84 | 4.00 | 700.0 | 0.00 | 0 | 79.37 | 352.38 | 0.00 | 0 | 79.37 | -48.59 |
| 2020 (7) | 2.85 | -20.61 | 0.50 | -75.0 | 3.90 | 95.0 | 17.54 | -68.51 | 136.84 | 145.63 | 154.39 | 38.56 |
| 2019 (6) | 3.59 | -25.21 | 2.00 | -33.33 | 2.00 | 0 | 55.71 | -10.86 | 55.71 | 0 | 111.42 | 78.27 |
| 2018 (5) | 4.80 | -14.13 | 3.00 | 0 | 0.00 | 0 | 62.50 | 0 | 0.00 | 0 | 62.50 | 0 |
| 2017 (4) | 5.59 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.38 | -22.45 | 375.0 | 0.24 | -14.29 | 100.0 | 1.38 | 38.0 | 283.33 |
| 24Q2 (19) | 0.49 | -3.92 | 345.45 | 0.28 | 180.0 | 833.33 | 1.00 | 96.08 | 257.14 |
| 24Q1 (18) | 0.51 | 64.52 | 218.75 | 0.10 | 150.0 | -44.44 | 0.51 | -23.88 | 218.75 |
| 23Q4 (17) | 0.31 | 287.5 | -46.55 | 0.04 | -66.67 | -92.59 | 0.67 | 86.11 | -76.9 |
| 23Q3 (16) | 0.08 | -27.27 | -88.24 | 0.12 | 300.0 | -81.82 | 0.36 | 28.57 | -84.48 |
| 23Q2 (15) | 0.11 | -31.25 | -85.14 | 0.03 | -83.33 | -96.3 | 0.28 | 75.0 | -82.82 |
| 23Q1 (14) | 0.16 | -72.41 | -82.02 | 0.18 | -66.67 | -80.22 | 0.16 | -94.48 | -82.02 |
| 22Q4 (13) | 0.58 | -14.71 | -50.43 | 0.54 | -18.18 | -46.53 | 2.90 | 25.0 | -42.69 |
| 22Q3 (12) | 0.68 | -8.11 | -53.1 | 0.66 | -18.52 | -47.62 | 2.32 | 42.33 | -41.85 |
| 22Q2 (11) | 0.74 | -16.85 | -47.89 | 0.81 | -10.99 | -31.93 | 1.63 | 83.15 | -35.83 |
| 22Q1 (10) | 0.89 | -23.93 | -42.58 | 0.91 | -9.9 | 1.11 | 0.89 | -82.41 | -42.58 |
| 21Q4 (9) | 1.17 | -19.31 | -5.65 | 1.01 | -19.84 | 46.38 | 5.06 | 26.82 | 77.54 |
| 21Q3 (8) | 1.45 | 2.11 | 70.59 | 1.26 | 5.88 | 137.74 | 3.99 | 57.09 | 146.3 |
| 21Q2 (7) | 1.42 | -8.39 | 162.96 | 1.19 | 32.22 | 643.75 | 2.54 | 63.87 | 229.87 |
| 21Q1 (6) | 1.55 | 25.0 | 0 | 0.90 | 30.43 | 0 | 1.55 | -45.61 | 0 |
| 20Q4 (5) | 1.24 | 45.88 | 0 | 0.69 | 30.19 | 0 | 2.85 | 75.93 | 0 |
| 20Q3 (4) | 0.85 | 57.41 | 0.0 | 0.53 | 231.25 | 0.0 | 1.62 | 110.39 | 0.0 |
| 20Q2 (3) | 0.54 | 0 | 0.0 | 0.16 | 0 | 0.0 | 0.77 | 0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 0.94 | -1.25 | 0.69 | 10.26 | 12.42 | 2.94 | N/A | - | ||
| 2024/10 | 0.95 | -8.67 | 29.51 | 9.32 | 13.75 | 2.96 | N/A | - | ||
| 2024/9 | 1.04 | 8.47 | 35.81 | 8.37 | 12.2 | 3.16 | 0.55 | - | ||
| 2024/8 | 0.96 | -17.04 | 1.46 | 7.33 | 9.49 | 3.01 | 0.57 | - | ||
| 2024/7 | 1.16 | 30.01 | 23.29 | 6.37 | 10.81 | 3.08 | 0.56 | - | ||
| 2024/6 | 0.89 | -13.64 | 20.47 | 5.21 | 8.37 | 2.86 | 0.69 | - | ||
| 2024/5 | 1.03 | 10.93 | 32.53 | 4.31 | 6.17 | 2.83 | 0.7 | - | ||
| 2024/4 | 0.93 | 7.36 | 31.49 | 3.28 | -0.08 | 2.43 | 0.82 | - | ||
| 2024/3 | 0.87 | 38.08 | -4.84 | 2.35 | -8.76 | 2.35 | 0.94 | - | ||
| 2024/2 | 0.63 | -26.58 | -32.4 | 1.48 | -10.9 | 2.3 | 0.97 | - | ||
| 2024/1 | 0.86 | 5.29 | 16.23 | 0.86 | 16.23 | 2.6 | 0.85 | - | ||
| 2023/12 | 0.81 | -13.06 | -15.7 | 9.94 | -34.21 | 2.48 | 0.84 | - | ||
| 2023/11 | 0.93 | 27.0 | -15.33 | 9.13 | -35.47 | 2.44 | 0.85 | - | ||
| 2023/10 | 0.74 | -4.23 | -36.04 | 8.2 | -37.17 | 2.45 | 0.85 | - | ||
| 2023/9 | 0.77 | -18.96 | -42.81 | 7.46 | -37.28 | 2.66 | 0.84 | - | ||
| 2023/8 | 0.95 | 0.8 | -29.81 | 6.69 | -36.58 | 2.63 | 0.85 | - | ||
| 2023/7 | 0.94 | 27.04 | -25.87 | 5.74 | -37.57 | 2.46 | 0.91 | - | ||
| 2023/6 | 0.74 | -4.99 | -40.65 | 4.8 | -39.44 | 2.23 | 1.07 | - | ||
| 2023/5 | 0.78 | 10.06 | -40.46 | 4.06 | -39.21 | 2.4 | 1.0 | - | ||
| 2023/4 | 0.71 | -22.3 | -41.71 | 3.28 | -38.91 | 2.55 | 0.94 | - | ||
| 2023/3 | 0.91 | -1.9 | -35.85 | 2.58 | -38.09 | 2.58 | 0.93 | - | ||
| 2023/2 | 0.93 | 26.24 | -26.97 | 1.66 | -39.25 | 2.63 | 0.91 | - | ||
| 2023/1 | 0.74 | -23.63 | -49.89 | 0.74 | -49.89 | 2.8 | 0.86 | - | ||
| 2022/12 | 0.96 | -12.67 | -37.75 | 15.11 | -16.96 | 3.22 | 0.73 | - | ||
| 2022/11 | 1.1 | -4.06 | -35.14 | 14.15 | -15.03 | 3.6 | 0.65 | - | ||
| 2022/10 | 1.15 | -14.37 | -27.29 | 13.05 | -12.74 | 3.84 | 0.61 | - | ||
| 2022/9 | 1.34 | -0.52 | -18.68 | 11.9 | -11.02 | 3.96 | 0.59 | - | ||
| 2022/8 | 1.35 | 6.44 | -20.74 | 10.55 | -9.94 | 3.87 | 0.61 | - | ||
| 2022/7 | 1.27 | 1.71 | -24.59 | 9.2 | -8.1 | 3.83 | 0.61 | - | ||
| 2022/6 | 1.25 | -4.69 | -24.83 | 7.93 | -4.77 | 3.77 | 0.62 | - | ||
| 2022/5 | 1.31 | 7.75 | -11.08 | 6.69 | 0.21 | 3.94 | 0.59 | - | ||
| 2022/4 | 1.21 | -14.49 | -14.7 | 5.38 | 3.42 | 3.91 | 0.6 | - | ||
| 2022/3 | 1.42 | 11.67 | 2.24 | 4.16 | 10.26 | 4.16 | 0.57 | - | ||
| 2022/2 | 1.27 | -13.37 | 18.54 | 2.74 | 14.93 | 4.29 | 0.56 | - | ||
| 2022/1 | 1.47 | -5.14 | 11.97 | 1.47 | 11.97 | 4.72 | 0.51 | - | ||
| 2021/12 | 1.55 | -9.02 | 17.06 | 18.2 | 54.56 | 4.83 | 0.43 | 本年度受惠於東南亞因疫情影響產生之轉單效應及巿場需求增加，致今年營收較去年同期增加。 | ||
| 2021/11 | 1.7 | 7.54 | 36.97 | 16.65 | 59.3 | 4.94 | 0.42 | 本年度受惠於東南亞因疫情影響產生之轉單效應及巿場需求增加，致今年營收較去年同期增加。 | ||
| 2021/10 | 1.58 | -4.23 | 37.94 | 14.95 | 62.31 | 4.94 | 0.42 | 去年同期受新冠疫情衝擊，今年則受惠於東南亞因疫情影響產生之轉單效應及巿場需求增加，致今年營收較去年同期增加。 | ||
| 2021/9 | 1.65 | -3.04 | 45.89 | 13.37 | 65.78 | 5.04 | 0.35 | 去年同期受新冠疫情衝擊，今年則受惠於東南亞因疫情影響產生之轉單效應及巿場需求增加，致今年營收較去年同期增加。 | ||
| 2021/8 | 1.7 | 1.27 | 68.43 | 11.72 | 69.03 | 5.05 | 0.34 | 去年同期受新冠疫情衝擊，今年則受惠於東南亞因疫情影響產生之轉單效應及巿場需求增加，致今年營收較去年同期增加。 | ||
| 2021/7 | 1.68 | 1.38 | 91.08 | 10.01 | 69.13 | 4.81 | 0.36 | 去年同期受新冠疫情衝擊，今年市場需求回升，以致今年營收較去年同期增加。 | ||
| 2021/6 | 1.66 | 12.73 | 121.34 | 8.33 | 65.3 | 4.56 | 0.37 | 去年同期受新冠疫情衝擊，今年市場需求回升，以致今年營收較去年同期增加。 | ||
| 2021/5 | 1.47 | 3.37 | 228.26 | 6.67 | 55.5 | 4.29 | 0.39 | 去年同期受新冠疫情衝擊，今年市場需求回升，以致今年營收較去年同期增加。 | ||
| 2021/4 | 1.42 | 2.49 | 175.76 | 5.2 | 35.33 | 3.89 | 0.43 | 去年同期受新冠疫情衝擊，今年市場需求回升，以致今年營收較去年同期增加。 | ||
| 2021/3 | 1.39 | 29.48 | 40.43 | 3.77 | 13.52 | 3.77 | 0.5 | - | ||
| 2021/2 | 1.07 | -18.17 | -6.01 | 2.38 | 2.11 | 3.71 | 0.51 | - | ||
| 2021/1 | 1.31 | -0.83 | 9.9 | 1.31 | 9.9 | 3.88 | 0.48 | - | ||
| 2020/12 | 1.32 | 6.45 | 7.85 | 11.78 | -18.8 | 3.71 | 0.46 | - | ||
| 2020/11 | 1.24 | 8.3 | 3.16 | 10.45 | -21.26 | 3.52 | 0.48 | - | ||
| 2020/10 | 1.15 | 1.28 | -6.86 | 9.21 | -23.69 | 3.29 | 0.52 | - | ||
| 2020/9 | 1.13 | 11.93 | -4.08 | 8.06 | -25.61 | 3.02 | 0.7 | - | ||
| 2020/8 | 1.01 | 14.89 | -20.66 | 6.93 | -28.24 | 2.64 | 0.8 | - | ||
| 2020/7 | 0.88 | 17.43 | -39.92 | 5.92 | -29.39 | 2.08 | 1.02 | - | ||
| 2020/6 | 0.75 | 67.19 | -38.88 | 5.04 | -30.73 | 1.71 | 1.49 | - | ||
| 2020/5 | 0.45 | -13.15 | -69.93 | 4.29 | -29.07 | 1.95 | 1.3 | 本月營收較去年同期減少，主要受新冠病毒疫情影響,客戶訂單交期遞延所致 | ||
| 2020/4 | 0.52 | -47.8 | -57.1 | 3.84 | -15.7 | 2.65 | 0.96 | 本月營收較去年同期減少，主要受新冠病毒疫情影響,客戶訂單交期遞延所致 | ||
| 2020/3 | 0.99 | -13.34 | -11.72 | 3.32 | -0.83 | 3.32 | 0.0 | - | ||
| 2020/2 | 1.14 | -4.31 | 47.01 | 2.34 | 11.34 | 3.56 | 0.0 | - | ||
| 2020/1 | 1.19 | -2.67 | -9.63 | 1.19 | -9.63 | 0.0 | N/A | - | ||
| 2019/12 | 1.23 | 1.82 | 12.77 | 14.5 | -8.08 | 0.0 | N/A | - |
